Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Rifabutin
Drug ID BADD_D01935
Description A broad-spectrum antibiotic that is being used as prophylaxis against disseminated Mycobacterium avium complex infection in HIV-positive patients.
Indications and Usage For the prevention of disseminated Mycobacterium avium complex (MAC) disease in patients with advanced HIV infection.
Marketing Status approved; investigational
ATC Code J04AB04
DrugBank ID DB00615
KEGG ID D00424
MeSH ID D017828
PubChem ID 135398743
TTD Drug ID D05CHI
NDC Product Code 70518-3731; 73309-108; 68180-285; 10135-738; 0013-5301; 59762-1350; 70954-041
UNII 1W306TDA6S
Synonyms Rifabutin | Rifabutine | Ansamycin | Mycobutin | Ansatipine | LM-427 | LM 427 | LM427 | Alfacid | Ansatipin
Chemical Information
Molecular Formula C46H62N4O11
CAS Registry Number 72559-06-9
SMILES CC1C=CC=C(C(=O)N=C2C(=C3C(=C4C2=NC5(N4)CCN(CC5)CC(C)C)C6=C(C(=C3O)C)OC(C6=O)(OC= CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)O)C
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Acute hepatic failure09.01.03.0010.021874%-
Agranulocytosis01.02.03.001---
Alanine aminotransferase increased13.03.04.005--
Anaemia01.03.02.001--
Angioedema10.01.05.009; 22.04.02.008; 23.04.01.001---
Aphasia17.02.03.001; 19.21.01.001--
Arthralgia15.01.02.001--
Aspartate aminotransferase increased13.03.04.011--
Asthenia08.01.01.0010.032082%-
Bacteraemia11.01.11.001--
Blood bilirubin increased13.03.04.018--
Body temperature increased13.15.01.001---
Bronchospasm10.01.03.012; 22.03.01.004--
Burkitt's lymphoma01.15.04.001; 16.28.04.001---
Chest discomfort02.02.02.009; 08.01.08.019; 22.12.02.002---
Chest pain02.02.02.011; 08.01.08.002; 22.12.02.003---
Chromaturia20.02.01.002--
Chronic obstructive pulmonary disease22.03.01.0070.014583%-
Clostridium difficile colitis07.19.01.004; 11.02.02.004---
Confusional state17.02.03.005; 19.13.01.001--
Congenital anomaly03.02.01.001---
Conjunctivitis06.04.01.002; 11.01.06.012--
Corneal deposits06.06.03.0020.014583%-
Cough22.02.03.0010.014583%
Dermatitis23.03.04.002---
Developmental delay08.01.03.037; 19.07.05.003---
Diarrhoea07.02.01.001--
Drug hypersensitivity10.01.01.0010.131245%-
Drug ineffective08.06.01.0060.088955%-
The 1th Page    1 2 3 4    Next   Last    Total 4 Pages